Literature DB >> 17109130

CD8(+) T cells armed with retrovirally transduced IFN-gamma.

Christian Becker1, Stefan Lienenklaus, Jadwiga Jablonska, Heike Bauer, Siegfried Weiss.   

Abstract

Interferon-gamma (IFN-gamma) is considered a key cytokine involved in the preventive and defensive responses of T cells against infectious pathogens and tumors. Therefore, the transgenic expression of IFN-gamma in specific T cells appears to be an obvious therapeutic possibility. To directly examine whether IFN-gamma production can be increased in T cells, we introduced an IFN-gamma encoding cDNA into IFN-gamma(-/-) and IFN-gamma(+/+) CD8(+) effector populations by retroviral transduction. Here, we show that CD8 T cells can be equipped with IFN-gamma that increases their capacity to secrete the cytokine. Despite constitutive retroviral IFN-gamma mRNA transcription, translation and secretion of IFN-gamma protein was tightly regulated and only observed in activated T cells. Neither proliferation nor cytolytic activity of CTL was affected by IFN-gamma transduction. Importantly, CD8(+) T cells retrovirally transduced with IFN-gamma exhibit augmented tumor suppressive capacity upon adoptive transfer into IFN-gamma(-/-) mice. Thus, T cells can be readily armed with IFN-gamma without risking immunopathology by dysregulated production of this highly potent proinflammatory cytokine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109130     DOI: 10.1007/s00109-006-0107-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  32 in total

1.  Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.

Authors:  R A Kemp; F Ronchese
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

2.  The JAM test. A simple assay for DNA fragmentation and cell death.

Authors:  P Matzinger
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

3.  Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-gamma gene.

Authors:  S Miyatake; K Nishihara; H Kikuchi; J Yamashita; Y Namba; M Hanaoka; Y Watanabe
Journal:  J Natl Cancer Inst       Date:  1990-02-07       Impact factor: 13.506

4.  A role of interferon-gamma (IFN-gamma) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in IFN-gamma-deficient mice.

Authors:  C Nakajima; Y Uekusa; M Iwasaki; N Yamaguchi; T Mukai; P Gao; M Tomura; S Ono; T Tsujimura; H Fujiwara; T Hamaoka
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

5.  IFN-gamma represses IL-4 expression via IRF-1 and IRF-2.

Authors:  Bernd Elser; Michael Lohoff; Sonja Kock; Marco Giaisi; Sabine Kirchhoff; Peter H Krammer; Min Li-Weber
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

6.  Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases.

Authors:  M J Dobrzanski; J B Reome; R W Dutton
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

7.  T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.

Authors:  W Böhm; S Thoma; F Leithäuser; P Möller; R Schirmbeck; J Reimann
Journal:  J Immunol       Date:  1998-07-15       Impact factor: 5.422

8.  Impaired infiltration of tumor-specific cytolytic T cells in the absence of interferon-gamma despite their normal maturation in lymphoid organs during CD137 monoclonal antibody therapy.

Authors:  Ryan A Wilcox; Dallas B Flies; Hao Wang; Koji Tamada; Aaron J Johnson; Larry R Pease; Moses Rodriguez; Yajun Guo; Lieping Chen
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

9.  Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

Authors:  R J Barth; J J Mulé; P J Spiess; S A Rosenberg
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice.

Authors:  L M Staudt; W Gerhard
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  1 in total

1.  CD8 engineered cytotoxic T cells reprogram melanoma tumor environment.

Authors:  Julie Leignadier; Stephanie Favre; Sanjiv A Luther; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2015-09-11       Impact factor: 8.110

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.